Live

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

The True Post icon
By The True Post
No Comments
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.

Source: CNBC

Share This Article
The True Post icon
ByThe True Post
The newsroom of The True Post.
Leave a Comment

Related Stories

Uncover the stories that related to the post!
30 partially clothed men found in frat basement in alleged hazing incident
Live

30 partially clothed men found in frat basement in alleged hazing incident

Fetterman says it's "entirely possible" for Democrats to take back Senate in midterms
Live

Fetterman says it's "entirely possible" for Democrats to take back Senate in midterms

Melania Trump rings NYSE opening bell to launch new women's initiative Imperia
Live

Melania Trump rings NYSE opening bell to launch new women's initiative Imperia

Parts of key U.S. military equipment may be in China's hands
Live

Parts of key U.S. military equipment may be in China's hands

Trump’s green flag waving at IndyCar race becomes instant viral hit
Live

Trump’s green flag waving at IndyCar race becomes instant viral hit

Investigators probing motive in cockpit attack on Israel-bound FlyDubai flight
Live

Investigators probing motive in cockpit attack on Israel-bound FlyDubai flight

Passenger on FlyDubai flight describes people falling, screaming for help as plane nosedived
Live

Passenger on FlyDubai flight describes people falling, screaming for help as plane nosedived

India readies $25 billion for Deep Tech investment as U.S. and China race ahead
Live

India readies $25 billion for Deep Tech investment as U.S. and China race ahead

Show More